Opportunity Information: Apply for HRSA 17 078
The Sickle Cell Disease Treatment Demonstration Regional Collaboratives Program (HRSA 17-078) is a discretionary federal funding opportunity from the U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA). It uses a cooperative agreement model, which typically means awardees are expected to work closely with the federal project team and participate in coordinated, multi-site planning and implementation rather than operating entirely independently. The program is designed to fund a small number of Regional Coordinating Centers (RCCs) that will serve as hubs for organizing and strengthening sickle cell disease (SCD) care across defined regions, with an emphasis on building sustainable systems that improve both prevention and treatment.
At the core of the opportunity is the expectation that each RCC will establish and lead a regional network that can drive statewide and regional activities to improve the quality and consistency of SCD care. The program prioritizes expanding the number of clinicians who treat people with SCD using evidence-based standards, specifically the National Heart, Lung and Blood Institute (NHLBI) Evidence-Based Management of Sickle Cell Disease Expert Panel Report. In practical terms, applicants are expected to focus on spreading and normalizing these guideline-based practices across a wider range of providers and settings, so that evidence-based care is not limited to a small number of specialty centers.
A major strategy highlighted in the announcement is the use of telementoring, telemedicine, and other provider support approaches to extend specialty knowledge and increase the capacity of clinicians who may not otherwise have deep experience with SCD. Telemedicine, as referenced through the American Telemedicine Association definition, includes the exchange of medical information through electronic communications such as two-way video, email, smartphones, wireless tools, and related technologies, with the goal of improving a patient’s clinical health status. In this grant context, telehealth-enabled methods are positioned as tools to support clinical decision-making, increase access to expertise, and reduce geographic barriers to high-quality SCD management.
The opportunity also places strong emphasis on improving access to quality care in ways that reflect the real-life needs of individuals and families living with SCD. RCCs are expected to develop and implement strategies that promote patient and family engagement and partnership in care, strengthen transition supports for adolescents and young adults moving from pediatric to adult systems, and encourage care models aligned with a medical home approach. The medical home emphasis signals interest in coordinated, continuous, patient-centered care that connects specialty and primary care, improves care navigation, and supports broader health and social needs that influence outcomes for people with SCD.
Operationally, the funding opportunity anticipated making about five awards. The listing does not specify an award ceiling in the provided source data. The CFDA number associated with the program is 93.365. Eligibility is broadly categorized as “Others,” with the expectation that applicants consult the additional eligibility details in the full announcement for clarification. The original posting date was November 10, 2016, with an original application deadline of January 13, 2017, indicating the specific cycle referenced is historical, but the summary reflects the program’s intended structure, priorities, and required focus areas.
In summary, this program funds regional hubs that organize networks, spread NHLBI guideline-based SCD care, and use telehealth-enabled support to grow the provider workforce delivering evidence-based management. It additionally targets systemic improvements that make care easier to access and navigate, particularly for families, for youth transitioning to adult care, and for patients needing coordinated services within a medical home framework.Apply for HRSA 17 078
- The Department of Health and Human Services, Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Sickle Cell Disease Treatment Demonstration Regional Collaboratives Program" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.365.
- This funding opportunity was created on Nov 10, 2016.
- Applicants must submit their applications by Jan 13, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 5 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
1) What is the Sickle Cell Disease Treatment Demonstration Regional Collaboratives Program (HRSA 17-078)?
It is a discretionary federal funding opportunity administered by the U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA). The program is designed to support regional efforts to improve prevention and treatment for sickle cell disease (SCD) by strengthening systems of care and spreading evidence-based clinical practices.
2) What does HRSA mean by a "cooperative agreement" for this program?
The opportunity uses a cooperative agreement model, meaning awardees are expected to work closely with the federal project team. Instead of operating fully independently, recipients typically participate in coordinated, multi-site planning and implementation activities with HRSA and other awardees as part of a broader, aligned effort.
3) What types of organizations or entities can apply?
Eligibility is categorized as "Others" in the provided information. The summary indicates applicants should consult the full announcement for the additional eligibility details and requirements.
4) How many awards were anticipated under this funding opportunity?
The opportunity anticipated making about five awards.
5) Is there an award ceiling (maximum funding amount) listed?
An award ceiling is not specified in the provided source information.
6) What is the CFDA number for this program?
The CFDA number associated with this program is 93.365.
7) What is an RCC (Regional Coordinating Center) in the context of this grant?
An RCC is a Regional Coordinating Center funded to function as a hub for organizing and strengthening SCD care across a defined region. RCCs are expected to lead regional networks and drive statewide and regional activities that improve the quality, consistency, and sustainability of SCD care.
8) What is the main purpose of funding RCCs?
The program is focused on building sustainable systems that improve SCD prevention and treatment. RCCs are expected to establish and lead regional networks, expand the number of clinicians delivering evidence-based SCD care, and improve access to quality services that better reflect the real-life needs of individuals and families living with SCD.
9) What kind of regional activities are RCCs expected to lead?
RCCs are expected to organize a regional network that can carry out statewide and regional initiatives to improve SCD care quality and consistency. The emphasis is on coordinated planning and implementation that strengthens systems of care rather than isolated, single-site improvements.
10) Which clinical standards or guidelines does the program prioritize?
The program prioritizes expanding the use of evidence-based standards, specifically the National Heart, Lung and Blood Institute (NHLBI) Evidence-Based Management of Sickle Cell Disease Expert Panel Report. Applicants are expected to focus on spreading and normalizing these guideline-based practices across more providers and care settings.
11) What does "expanding the number of clinicians who treat people with SCD" mean here?
In this program, it means increasing the number of providers who can competently deliver SCD care using evidence-based standards, so high-quality management is not limited to a small number of specialty centers. The goal is broader, more consistent adoption of guideline-based care across regions.
12) How does telehealth fit into this program?
Telehealth-enabled methods are highlighted as a major strategy to extend specialty knowledge and increase the capacity of clinicians who may not have deep experience with SCD. The opportunity emphasizes telementoring, telemedicine, and other provider support approaches to help clinical decision-making, improve access to expertise, and reduce geographic barriers to high-quality SCD management.
13) What does the announcement mean by "telemedicine"?
Telemedicine is referenced using the American Telemedicine Association definition: the exchange of medical information through electronic communications such as two-way video, email, smartphones, wireless tools, and related technologies, with the goal of improving a patient's clinical health status.
14) Are telementoring and telemedicine aimed at patients, providers, or both?
Based on the provided summary, these approaches are positioned primarily as provider support tools. They are intended to extend specialty knowledge, support clinical decision-making, and increase clinicians' capacity to manage SCD using evidence-based practices, while also helping reduce geographic barriers that affect patient access to high-quality care.
15) What populations or care moments does the program emphasize?
The program places strong emphasis on addressing real-life needs of individuals and families living with SCD, with specific attention to adolescents and young adults transitioning from pediatric to adult care systems, as well as broader patient and family engagement and partnership in care.
16) What is expected related to patient and family engagement?
RCCs are expected to develop and implement strategies that promote patient and family engagement and partnership in care, reflecting the program's focus on making SCD care more accessible, navigable, and aligned with the needs of patients and families.
17) What does the program require or encourage regarding transition from pediatric to adult care?
RCCs are expected to strengthen transition supports for adolescents and young adults moving from pediatric to adult systems. This is presented as a major priority area for improving continuity and quality of SCD care.
18) What does "medical home approach" mean in this grant summary?
The medical home emphasis signals interest in coordinated, continuous, patient-centered care that connects specialty and primary care, improves care navigation, and supports broader health and social needs that influence outcomes for people with SCD.
19) Is this opportunity current or historical?
The provided timeline indicates the specific cycle referenced is historical. The original posting date was November 10, 2016, and the original application deadline was January 13, 2017. The summary still reflects the program's intended structure, priorities, and focus areas.
20) What are the key themes an applicant would need to address based on the summary?
The summary points to several core expectations: building a regional network led by an RCC, expanding guideline-based SCD care using the NHLBI expert panel report, using telehealth-enabled methods (including telementoring and telemedicine) to extend expertise and build provider capacity, improving access to quality care, strengthening patient and family engagement, supporting pediatric-to-adult transitions, and promoting coordinated care aligned with a medical home approach.
Browse more opportunities from the same category: Health
Next opportunity: Cooperative Ecosystem Studies Unit, Great Lakes Northern Forests CESU
Previous opportunity: Strengthening Public Health Systems in the Caribbean by supporting the Caribbean Public Health Agency (CARPHA) under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 17 078
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 17 078) also looked into and applied for these:
| Funding Opportunity |
|---|
| Health Care Delivery System Innovations for Children with Medical Complexity Apply for HRSA 17 100 Funding Number: HRSA 17 100 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Data and Resource Generation Centers for Illuminating the Druggable Genome (U24) Apply for RFA RM 16 026 Funding Number: RFA RM 16 026 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $1,600,000 |
| Home Visiting Collaborative Improvement and Innovation Network: Series 2 (HV CoIIN 2.0) Apply for HRSA 17 102 Funding Number: HRSA 17 102 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Home Visiting Research and Development Platform Apply for HRSA 17 101 Funding Number: HRSA 17 101 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Protecting and Improving Public Health Systems Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security, Center for Global Health Apply for CDC RFA GH15 162702CONT17 Funding Number: CDC RFA GH15 162702CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Predoctoral Pediatric Training in General Dentistry and Dental Hygiene Apply for HRSA 17 068 Funding Number: HRSA 17 068 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Medicare Access and CHIP Re-authorization Act Apply for CMS 1Z0 17 001 Funding Number: CMS 1Z0 17 001 Agency: Department of Health and Human Services, Centers for Medicare Medicaid Services Category: Health Funding Amount: $500,000 |
| Development and Evaluation of Sports Concussion Prevention Strategies Apply for RFA CE 17 002 Funding Number: RFA CE 17 002 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $550,000 |
| Evaluation of Models of PrEP Service Delivery at Title X and STD Clinics Apply for RFA PS 17 004 Funding Number: RFA PS 17 004 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $2,000,000 |
| Ranfose Abitid Nitrisyon pou Fè Ogmante Sante (RANFOSE) Apply for RFA 521 17 000002 Funding Number: RFA 521 17 000002 Agency: Agency for International Development, Haiti USAID-Port Au Prince Category: Health Funding Amount: $4,000,000 |
| Household Transmission of Influenza Viruses in the Community Apply for RFA IP 17 001 Funding Number: RFA IP 17 001 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $500,000 |
| Ryan White HIV/AIDS Program Implementation Center for HIV Clinical Quality Improvement Apply for HRSA 17 034 Funding Number: HRSA 17 034 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Systems Biology: The Next Generation for Infectious Diseases (U19) Apply for RFA AI 16 080 Funding Number: RFA AI 16 080 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Protecting and Strengthening Public Health Impact, Systems, Capacity, and Security Apply for CDC RFA GH14 141803CONT17 Funding Number: CDC RFA GH14 141803CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Rapid-Cycle Survey Collaborative for Provider Input on Immunization Issues Apply for RFA IP 17 003 Funding Number: RFA IP 17 003 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $450,000 |
| Centers for Disease Control and Prevention Minority HIV/AIDS Research Initiative (MARI) to Build HIV Prevention, Treatment and Research Capacity in Disproportionately Affected Black and Hispanic Communities and Among Historically Underrepresented Res Apply for RFA PS 16 00102CONT17 Funding Number: RFA PS 16 00102CONT17 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: Case Dependent |
| Addressing Emerging Zoonoses and Strengthening Animal and Human Health Systems Apply for CDC RFA CK17 1702 Funding Number: CDC RFA CK17 1702 Agency: Department of Health and Human Services, Centers for Disease Control - NCEZID Category: Health Funding Amount: Case Dependent |
| Medical Monitoring Project (MMP) Apply for CDC RFA PS15 150303CONT17 Funding Number: CDC RFA PS15 150303CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| Integrated Approaches to HIV-Related Heart, Lung, Blood, and Sleep (HLBS) Comorbidities (R01) Apply for RFA HL 18 004 Funding Number: RFA HL 18 004 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $499,999 |
| Limited Competition: NIH Health Care Systems Research Collaboratory - Coordinating Center (U24) Apply for RFA RM 16 018 Funding Number: RFA RM 16 018 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $2,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 17 078", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.